News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ENDECE Neural To Present Updated Data At ASN Annual Meeting Showing NDC-1308 Induces Remyelination In Multiple Sclerosis (MS)


3/7/2014 6:54:15 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Scientists from ENDECE Neural announced today that new pre-clinical evidence that the company’s lead compound, NDC-1308, induces remyelination in experimental models of MS will be presented at the 45th annual meeting of the American Society for Neurochemistry (ASN) in Long Beach, Calif.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES